These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22388835)

  • 1. [Apheresis in the treatment of vasculitis].
    Somenzi D; Corradini M; Pasquali S
    G Ital Nefrol; 2012; 29 Suppl 54():S73-7. PubMed ID: 22388835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of rituximab in the treatment of ANCA-associated systemic vasculitis].
    Roccatello D; Vangelista A; Pani A
    G Ital Nefrol; 2011; 28(5):474-88. PubMed ID: 22028261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis to treat systemic vasculitis.
    Moussi-Frances J; Sallée M; Jourde-Chiche N
    Joint Bone Spine; 2018 Mar; 85(2):177-183. PubMed ID: 28602810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA vasculitis: time for a change in treatment paradigm? Not yet.
    Ntatsaki E; Mooney J; Watts RA
    Rheumatology (Oxford); 2011 Jun; 50(6):1019-24. PubMed ID: 21292735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapillary glomerulonephritis type I with the coexistence of positive anti-GBM and p-ANCA antibodies.
    Toledo Perdomo K; Ortega Salas R; Pérez-Sáez MJ; Esquivias de Motta E; Espinosa Hernández M; López Andreu M; López Rubio F; Aljama García P
    Nefrologia; 2011; 31(1):113-5. PubMed ID: 21270926
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression.
    de Joode AA; Sanders JS; Smid WM; Stegeman CA
    J Clin Apher; 2014 Oct; 29(5):266-72. PubMed ID: 24497412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rituximab for the treatment of ANCA associated vasculitis: the future today?].
    Alba MA; Flores-Suárez LF
    Reumatol Clin; 2011 Dec; 7 Suppl 3():S41-6. PubMed ID: 22115869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term patient survival in ANCA-associated vasculitis.
    Flossmann O; Berden A; de Groot K; Hagen C; Harper L; Heijl C; Höglund P; Jayne D; Luqmani R; Mahr A; Mukhtyar C; Pusey C; Rasmussen N; Stegeman C; Walsh M; Westman K;
    Ann Rheum Dis; 2011 Mar; 70(3):488-94. PubMed ID: 21109517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmapheresis therapy in ANCA-associated vasculitides: A single-center retrospective analysis of renal outcome and mortality.
    Solar-Cafaggi D; Atisha-Fregoso Y; Hinojosa-Azaola A
    J Clin Apher; 2016 Oct; 31(5):411-8. PubMed ID: 26194633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis in diffuse alveolar hemorrhage as perinuclear antineutrophil cytoplasmic antibody-associated vasculitis relapse on hemodialysis.
    Cigarrán S; Castro MJ; Pousa M; Paredes S; Bernardo H; Porteiro M
    Ther Apher Dial; 2010 Jun; 14(3):368-72. PubMed ID: 20609194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody-associated vasculitis complicated with diffuse alveolar hemorrhage: a study of 12 cases.
    Lin Y; Zheng W; Tian X; Zhang X; Zhang F; Dong Y
    J Clin Rheumatol; 2009 Oct; 15(7):341-4. PubMed ID: 20009969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of post-transplant glomerulonephritis].
    Sandrini S; Valerio F
    G Ital Nefrol; 2008; 25 Suppl 44():99-106. PubMed ID: 19048593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrotizing vasculitis--a 2009 update.
    Sharaf PH; Yazici Y
    Bull NYU Hosp Jt Dis; 2009; 67(3):303-5. PubMed ID: 19852754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcomes of ANCA-associated renal vasculitis.
    Seck SM; Dussol B; Brunet P; Burtey S
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):301-5. PubMed ID: 22382223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
    Szabó MZ; Pálfi P; Bazsó A; Poór G; Kiss E
    Orv Hetil; 2015 Oct; 156(41):1653-60. PubMed ID: 26551168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vasculitis presenting with acute kidney injury.
    Villacorta J; Diaz-Crespo F; Acevedo M; Cavero T; Guerrero C; Praga M; Fernandez-Juarez G
    Rheumatol Int; 2017 Jun; 37(6):1035-1041. PubMed ID: 28289874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan.
    Itabashi M; Takei T; Yabuki Y; Suzuki H; Ando M; Akamatsu M; Yamazaki M; Mitobe M; Watanabe Y; Mochizuki T; Nitta K
    Nephron Clin Pract; 2010; 115(1):c21-7. PubMed ID: 20173346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-associated vasculitis with renal involvement: an outcome analysis.
    Weidner S; Geuss S; Hafezi-Rachti S; Wonka A; Rupprecht HD
    Nephrol Dial Transplant; 2004 Jun; 19(6):1403-11. PubMed ID: 15069175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic vasculitis: still a challenging disease.
    Buhaescu I; Covic A; Levy J
    Am J Kidney Dis; 2005 Aug; 46(2):173-85. PubMed ID: 16112036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of initial histology and effect of plasmapheresis on long-term prognosis of rapidly progressive glomerulonephritis.
    Zäuner I; Bach D; Braun N; Krämer BK; Fünfstück R; Helmchen U; Schollmeyer P; Böhler J
    Am J Kidney Dis; 2002 Jan; 39(1):28-35. PubMed ID: 11774098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.